367 related articles for article (PubMed ID: 9619914)
1. Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Banker DE; Groudine M; Willman CL; Norwood T; Appelbaum FR
Leuk Res; 1998 Mar; 22(3):221-39. PubMed ID: 9619914
[TBL] [Abstract][Full Text] [Related]
2. Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
Garrido SM; Cooper JJ; Appelbaum FR; Willman CL; Kopecky K; Banker DE
Leuk Res; 2001 Jan; 25(1):23-32. PubMed ID: 11137557
[TBL] [Abstract][Full Text] [Related]
3. Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
Banker DE; Groudine M; Norwood T; Appelbaum FR
Blood; 1997 Jan; 89(1):243-55. PubMed ID: 8978298
[TBL] [Abstract][Full Text] [Related]
4. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Garrido SM; Willman C; Appelbaum FR; Banker DE
Cytometry; 2000 Apr; 42(2):83-94. PubMed ID: 10797445
[TBL] [Abstract][Full Text] [Related]
5. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
Taub JW; Huang X; Matherly LH; Stout ML; Buck SA; Massey GV; Becton DL; Chang MN; Weinstein HJ; Ravindranath Y
Blood; 1999 Aug; 94(4):1393-400. PubMed ID: 10438727
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Garrido SM; Appelbaum FR; Willman CL; Banker DE
Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
[TBL] [Abstract][Full Text] [Related]
7. Comparative effects of G-CSF, GM-CSF and IL-3 on cytosine arabinoside- and daunorubicin-mediated cytotoxicity of acute myeloid leukemia cells and normal myeloid progenitors.
Waga K; Furusawa S; Nagashima S; Saito K; Shishido H
Int J Hematol; 1992 Aug; 56(1):17-27. PubMed ID: 1391803
[TBL] [Abstract][Full Text] [Related]
8. Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.
Rao J; Xu DR; Zheng FM; Long ZJ; Huang SS; Wu X; Zhou WH; Huang RW; Liu Q
J Transl Med; 2011 May; 9():71. PubMed ID: 21595920
[TBL] [Abstract][Full Text] [Related]
9. Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.
Heo SK; Noh EK; Yu HM; Kim DK; Seo HJ; Lee YJ; Cheon J; Koh SJ; Min YJ; Choi Y; Jo JC
BMC Cancer; 2020 Dec; 20(1):1193. PubMed ID: 33276759
[TBL] [Abstract][Full Text] [Related]
10. Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells.
Vial JP; Belloc F; Dumain P; Besnard S; Lacombe F; Boisseau MR; Reiffers J; Bernard P
Leuk Res; 1997 Feb; 21(2):163-72. PubMed ID: 9112434
[TBL] [Abstract][Full Text] [Related]
11. Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C.
Tina E; Prenkert M; Höglund M; Paul C; Tidefelt U
Oncol Rep; 2009 Dec; 22(6):1527-31. PubMed ID: 19885609
[TBL] [Abstract][Full Text] [Related]
12. Panobinostat enhances cytarabine and daunorubicin sensitivities in AML cells through suppressing the expression of BRCA1, CHK1, and Rad51.
Xie C; Drenberg C; Edwards H; Caldwell JT; Chen W; Inaba H; Xu X; Buck SA; Taub JW; Baker SD; Ge Y
PLoS One; 2013; 8(11):e79106. PubMed ID: 24244429
[TBL] [Abstract][Full Text] [Related]
13. PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.
Banker DE; Cooper JJ; Fennell DA; Willman CL; Appelbaum FR; Cotter FE
Leuk Res; 2002 Jan; 26(1):91-106. PubMed ID: 11734307
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
[TBL] [Abstract][Full Text] [Related]
15. The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.
Konopleva M; Zhao S; Hu W; Jiang S; Snell V; Weidner D; Jackson CE; Zhang X; Champlin R; Estey E; Reed JC; Andreeff M
Br J Haematol; 2002 Aug; 118(2):521-34. PubMed ID: 12139741
[TBL] [Abstract][Full Text] [Related]
16. The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.
Banker DE; Radich J; Becker A; Kerkof K; Norwood T; Willman C; Appelbaum FR
Clin Cancer Res; 1998 Dec; 4(12):3051-62. PubMed ID: 9865920
[TBL] [Abstract][Full Text] [Related]
17. Inv(16) acute myeloid leukemia cells show an increased sensitivity to cytosine arabinoside in vitro.
Tosi P; Visani G; Ottaviani E; Testoni N; Pellacani A; Tura S
Eur J Haematol; 1998 Mar; 60(3):161-5. PubMed ID: 9548414
[TBL] [Abstract][Full Text] [Related]
18. Intraclonal heterogeneity in the in vitro daunorubicin-induced apoptosis in acute myeloid leukemia.
Palucka KA; Knaust E; Xu D; Macnamara B; Porwit-Macdonald A; Gruber A; Peterson C; Björkholm M; Pisa P
Leuk Lymphoma; 1999 Jan; 32(3-4):309-16. PubMed ID: 10037028
[TBL] [Abstract][Full Text] [Related]
19. Colony-stimulating factors (rhG-CSF, rhGM-CSF, rhIL-3, and BCGF) recruit myeloblastic and lymphoblastic leukemic cells and enhance the cytotoxic effects of cytosine-arabinoside.
Andreeff M; Tafuri A; Hegewisch-Becker S
Haematol Blood Transfus; 1990; 33():747-62. PubMed ID: 2323674
[TBL] [Abstract][Full Text] [Related]
20. Combination of hematopoietic growth factors containing IL-3 induce acute myeloid leukemia cell sensitization to cycle specific and cycle non-specific drugs.
Tafuri A; Lemoli RM; Chen R; Gulati SC; Clarkson BD; Andreeff M
Leukemia; 1994 May; 8(5):749-57. PubMed ID: 7514244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]